The present invention is related to a live, attenuated virus composition comprising:one or more live, attenuated viruses；one or more albumins selected from the group consisting of lactalbumins and serum albumins, andtrehalose, wherein the composition is capable of reducing the inactivation of the live, attenuated virus.
